| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |